|
Kidney donation: research shows benefits of new 1-day screening
February 23, 2024
-
If you were thinking of becoming a living kidney donor, would you rather do all your screening appointments in one day, or spread them out over six months?
|
|
ELEVATE seed grants to help researchers at The Ottawa Hospital improve prevention and care for kidney disease
February 21, 2024
-
The Ottawa Hospital’s Research Institute is awarding five ELEVATE seed grants to kickstart innovative kidney research projects.
|
|
Three COVID-19 vaccine doses significantly reduced infection, severe outcomes in organ transplant recipients
September 14, 2022
-
Dr. Greg Knoll led one of the few real-world studies of the effectiveness of a third dose of COVID-19 vaccine among organ transplant recipients by using linked healthcare databases.
|
|
When Is Dead Really Dead?
February 17, 2021
-
Researchers at The Ottawa Hospital played a major role in a CHEO-led study published in the New England Journals of Medicine. The study, led by Dr. Sonny Dhanani, asked over 600 families to allow their loved ones in the ICU to have their vital signs
|
|
Stem cell treatment for scleroderma improves quality of life
February 17, 2021
-
When Dr. Nancy Maltez meets a patient with early severe systemic scleroderma, a rare autoimmune disease that hardens the skin and organs, she knows one of the best options is to reset their immune system using strong chemotherapy and a stem cell tran
|
|
$950,000 to help develop stem cell treatments for septic shock, lung injury and muscle degeneration
May 17, 2019
-
Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks to four new peer-reviewed research grants from the Ontario Institute for Regenerative Medici
|
|
Clinical trials offer strong foundation for better patient care
May 16, 2019
-
Clinical trials are an important step toward developing new treatments and learning more about diseases and conditions. In honour of International Clinical Trials Day, read how some of the researchers at The Ottawa Hospital are making huge contribut
|
|
Autologous hematopoietic stem cell transplantation recommended as a standard of care for certain kinds of MS in the U.S.
March 13, 2019
-
The American Society for Blood and Marrow Transplantation has recommended that stem cell transplantation for MS, which has been pioneered at The Ottawa Hospital, be considered a “standard of care, clinical evidence available” for people with certain
|
|
Access to kidney transplants unequal across Ontario: study
January 9, 2017
-
A study published in the American Journal of Transplantation found that chronic dialysis patients in Ontario have unequal access to kidney transplants. These patients with kidney failure will be on dialysis their whole lives unless they receive a
|
|
When drugs don’t work: research spares kidney transplant patients from unnecessary risks
January 21, 2016
-
Ottawa Resident Jim Ward, who received a kidney transplant from his brother in 2001, took part in an important eight-year study that showed a commonly prescribed drug doesn’t work nearly as well as previously thought and could potentially harm k
|